Lyra TherapeuticsLYRA
13F holders, Q2 2025 (June 30)30holders
$8.96avg. 13F price*
At the end of Q2 2025, 30 institutions reported holding Lyra Therapeutics Inc. (LYRA) in their 13F filings. The largest holders were Perceptive Advisors LLC ($2.3M), Sabby Management, LLC ($1.1M) and Vanguard Group Inc. ($261K).
- Company
- Lyra Therapeutics Inc.
- CUSIP
- 55234L204
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $1.2M |
| Exits | 0 | $0 |
Ownership 30 holders
| Perceptive Advisors LLC | 0.09% | No change | 255,150 | $2.3M |
| Sabby Management, LLC | 9.11% | New | 125,729 | $1.1M |
| Vanguard Group Inc. | 0.00% | Reduce -17.4% | 29,178 | $261K |
| Bank of America Corp. | 0.00% | Add +6583.7% | 28,542 | $256K |
| Ikarian Capital, LLC | 0.06% | No change | 21,161 | $190K |
| Geode Capital Management, LLC | 0.00% | Reduce -45.9% | 10,986 | $98K |
| State of Wisconsin Investment Board | 0.00% | New | 10,500 | $94K |
| Morgan Stanley | 0.00% | Add +64.9% | 2,164 | $19K |
| FMR LLC | 0.00% | Add +50.1% | 1,748 | $16K |
| BlackRock, Inc. | 0.00% | Reduce -97.2% | 1,690 | $15K |
| Russell Investments Group, Ltd. | 0.00% | New | 1,594 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +40.6% | 1,483 | $13K |
| Royal Bank of Canada | 0.00% | Add +587.1% | 1,102 | $10K |
| Citigroup Inc. | 0.00% | Add +13.0% | 795 | $7K |
| Valley National Advisers Inc. | 0.00% | New | 500 | $4K |
| Signature Resources Capital Management, LLC | 0.00% | New | 400 | $4K |
| EverSource Wealth Advisors, LLC | 0.00% | Add +5118.7% | 358 | $3K |
| Cwm, LLC | 0.00% | Add +51.3% | 202 | $2K |
| JPMorgan Chase & Co. | 0.00% | Reduce -82.9% | 192 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -0.5% | 85 | $762 |
| Barclays PLC | 0.00% | Reduce -95.2% | 48 | $430 |
| Wells Fargo & Company | 0.00% | Reduce -92.3% | 39 | $349 |
| BNP Paribas Financial Markets | 0.00% | Reduce -99.5% | 25 | $224 |
| Comerica Bank | 0.00% | Reduce -0.8% | 23 | $206 |
| Principal Securities, Inc. | 0.00% | New | 19 | $170 |
| Jones Financial Companies LLLP | 0.00% | No change | 10 | $91 |
| Nisa Investment Advisors, LLC | 0.00% | No change | 10 | $90 |
| Raymond James Financial Inc. | 0.00% | New | 8 | $72 |
| IFP Advisors, Inc | 0.00% | New | 6 | $54 |
| UBS Group AG | 0.00% | Reduce -100.0% | 2 | $18 |
"% of holder's portfolio" is LYRA's weight in each manager's 13F, not the share of Lyra Therapeutics Inc. the manager owns.